Desloratadine D4 | CAS 381727-29-3 - Request Quote
Desloratadine D4
| SZ CAT No: | SZ-D022D01 |
| CAS No | 381727-29-3 |
| Mol.F. | C19H15D4ClN2 |
| Mol.Wt. | 314.9 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Desloratadine D4 is chemically 8-Chloro-11-(piperidin-4-ylidene-2,2,6,6-d4)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine. Desloratadine D4 is supplied with detailed characterization data compliant with regulatory guideline. Desloratadine D4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Desloratadine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 381727-29-3
Purchase 381727-29-3
Order 381727-29-3
Enquire 381727-29-3
price of 381727-29-3
381727-29-3 Supplier
381727-29-3 Manufacturer
381727-29-3 Exporter
buy high quality Desloratadine D4
Purchase Desloratadine D4
Desloratadine D4 suppliers
Desloratadine D4 manufacturers
Desloratadine D4 price
Order Desloratadine D4
Enquire Desloratadine D4
Desloratadine D4 cost
Desloratadine D4 Supplier
Desloratadine D4 Distributor
Desloratadine D4 for Method Validation
Desloratadine Reference Standard
Desloratadine D4 for ANDA Filing
Desloratadine D4 for Forced Degradation Studies
Desloratadine D4 Identification Standards
Desloratadine D4 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


